GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » 6-1 Month Momentum %

Fisher & Paykel Healthcare (NZSE:FPH) 6-1 Month Momentum % : 23.26% (As of Apr. 30, 2024)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-30), Fisher & Paykel Healthcare's 6-1 Month Momentum % is 23.26%.

The industry rank for Fisher & Paykel Healthcare's 6-1 Month Momentum % or its related term are showing as below:

NZSE:FPH's 6-1 Month Momentum % is ranked better than
75.78% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: 0.7 vs NZSE:FPH: 23.26

Competitive Comparison of Fisher & Paykel Healthcare's 6-1 Month Momentum %

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's 6-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's 6-1 Month Momentum % falls into.



Fisher & Paykel Healthcare  (NZSE:FPH) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Fisher & Paykel Healthcare 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.